Supplier of oncology systems with chemotherapy and radiotherapy products joins supplier of integrated pathology IT solutions
Sysmed continues to expand its range of integrated clinical and diagnostic software applications with the announcement of the acquisition of Clinisis.
Clinisis is a supplier of oncology systems in the UK with over 30 sites.
Its product range has been continually expanded over the past ten years to encapsulate a broad range of functionality for the diagnosis and treatment of all cancers.
Its extensive chemotherapy module supports adult, paediatric and haematology prescribing - all accessible from any location within a given cancer network.
The radiotherapy solution delivers advanced scheduling facilities to coordinate complex inter-departmental treatment plans, enabling clinical managers to maximise the utilisation of high value resources.
Sysmed and Clinisis's complementary products offer extended solutions for cancer diagnosis, treatment and management to a marketplace where the need for IT solutions is all too evident.
Such systems are, says Sysmed, essential to support regional and national information processing requirements, and help realise the objectives of the Cancer National Service Framework (NSF).
